DOSAGE & ADMINISTRATION SECTION.
DIRECTIONS:ADULTS: APPLY SMALL AMOUNT AS THIN LAYER ON THE AFFECTED AREA TWICE DAILY, OR USE AS DIRECTED BY DOCTOR. IF NO IMPROVEMENT IS SEEN AFTER MONTHS OF TREATMENT, USE OF THIS PRODUCT SHOULD BE DISCONTINUED. LIGHTENING EFFECT OF THIS PRODUCT MAY NOT BE NOTICEABLE WHEN USED ON VERY DARK SKIN. CHILDREN UNDER 12 YEARS OF AGE: DO NOT USE UNLESS DIRECTED BY DOCTOR.
Citing DrugCentral © 2026. License
INACTIVE INGREDIENT SECTION.
INACTIVE INGREDIENTS:C13-14 ISOPARAFFIN, CETYL ALCOHOL, ETHYLHEXYLGLYCERIN, ETHYLHEXYL STEARATE, GLYCERIN, GLYCERYL STEARATE, GLYCOLIC ACID, ISOPROPYL MYRISTATE, LAURETH-7, NIACINAMIDE, PANTOTHENIC ACID, PEG-100 STEARATE, PHENOXYETHANOL, POLYACRYLAMIDE, PYRIDOXINE HCL, SODIUM HYDROXIDE, SODIUM METABISULFITE, TETRAHEXYLDECYL ASCORBATE, WATER (AQUA), XANTHAN GUM.
Citing DrugCentral © 2026. License
INDICATIONS & USAGE SECTION.
USES:FOR THE GRADUAL FADING OF DARK AREAS OF THE SKIN.
Citing DrugCentral © 2026. License
OTHER SAFETY INFORMATION.
THIS PRODUCT IS NOT INTENDED FOR USE IN THE PREVENTION OF SUNBURN AND CONTAINS AN ALPHA HYDROXY ACID (AHA) THAT MAY INCREASE YOUR SKINS SENSITIVITY TO THE SUN AND PARTICULARLY THE POSSIBILITY OF SUNBURN. SUN EXPOSURE SHOULD BE LIMITED BY USING SUNSCREEN AGENT OR PROTECTIVE CLOTHING TO COVER BLEACHED SKIN AFTER TREATMENT IS COMPLETED TO PREVENT DARKENING FROM REOCCURING.
Citing DrugCentral © 2026. License
OTC - ACTIVE INGREDIENT SECTION.
ACTIVE INGREDIENTS:HYDROQUINONE USP 2%.
Citing DrugCentral © 2026. License
OTC - KEEP OUT OF REACH OF CHILDREN SECTION.
KEEP OUT OF REACH OF CHILDREN.
Citing DrugCentral © 2026. License
OTC - PURPOSE SECTION.
PURPOSE:SKIN LIGHTENING.
Citing DrugCentral © 2026. License
OTC - QUESTIONS SECTION.
QUESTIONS 1-323-733-7033.
Citing DrugCentral © 2026. License
OTC - STOP USE SECTION.
IF IRRITATION BECOMES SEVERE, STOP USE AND CONSULT DOCTOR.
Citing DrugCentral © 2026. License
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL.
5LighteningLBL.
Citing DrugCentral © 2026. License
PEDIATRIC USE SECTION.
DO NOT USE ON CHILDREN UNDER 12 YEARS OF AGE UNLESS DIRECTED BY DOCTOR.
Citing DrugCentral © 2026. License
WARNINGS SECTION.
WARNINGS:AVOID CONTACT WITH EYES. SOME USERS MAY EXPERIENCE MILD SKIN IRRITATION.
Citing DrugCentral © 2026. License